As Yahoo struggles to find its place and relevance among more dynamic competitors, it is staking at least some of its future success on Genome, an audience-targeting platform it built with the recent acquisition of Interclick and inventory partnerships with AOL and MSN. The Genome platform enables marketers and brands to build data-rich targeting into their campaigns across Yahoo's vast inventory. Original Story
Any commercial link will be deleted and reported to Mollom as SPAM. As such, we highly recommend against including commercial links in comments. Even comments with a reasonable amount of relevancy to the subject will be deleted and reported as SPAM.